Antiplatelet Thrombolysin (Anfibatide) Phase 1 Clinical Trial in Healthy Volunteers

Clinical trial NCT04404790 · SUSPENDED

Trial details

NCT number: NCT04404790
Sponsor: Lee's Pharmaceutical Limited
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Antiplatelet Drug

Start date: 2020-09-01
Primary completion: 2021-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.